Yahoo
NYSE - Delayed Quote USD

Concord Medical Services Holdings Limited (CCM)

3.5700 -0.0900 (-2.46%)
At close: October 30 at 3:59:54 PM EDT
Chart Range Bar
Loading chart for CCM
  • Previous Close 3.6600
  • Open 3.5000
  • Bid 1.4400 x 20000
  • Ask 5.0000 x 20000
  • Day's Range 3.5700 - 3.7400
  • 52 Week Range 2.7900 - 6.8000
  • Volume 5,679
  • Avg. Volume 46,115
  • Market Cap (intraday) 15.5M
  • Beta (5Y Monthly) -0.81
  • PE Ratio (TTM) --
  • EPS (TTM) -3.0400
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date Dec 23, 2015
  • 1y Target Est --

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, and helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, China.

www.concordmedical.com

610

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/31/2026, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

CCM
5.31%
MSCI WORLD (^990100-USD-STRD)
9.75%

1-Year Return

CCM
34.97%
MSCI WORLD (^990100-USD-STRD)
10.75%

3-Year Return

CCM
67.84%
MSCI WORLD (^990100-USD-STRD)
75.63%

5-Year Return

CCM
85.55%
MSCI WORLD (^990100-USD-STRD)
0.00%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY13
Revenue 38.4M
Earnings --
Profit Margin 0.00%

Q2

FY11

Q3

FY11

Q2

FY13

Q3

FY13

0
10M
20M
30M
40M
0.0%
10.0%
20.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -20.15%

  • Return on Assets (ttm)

    -2.25%

  • Return on Equity (ttm)

    -21.88%

  • Revenue (ttm)

    460.51M

  • Net Income Avi to Common (ttm)

    -92.81M

  • Diluted EPS (ttm)

    -3.0400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    297.79M

  • Total Debt/Equity (mrq)

    196.47%

  • Levered Free Cash Flow (ttm)

    -313.65M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: